Japan’s Fujifilm stops work on Avigan as COVID drug
In March, Fujifilm had cut short enrolment in a phase-III trial, saying the emergence of the Omicron variant made it tough to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Fujifilm
Appili Therapeutics to partner with Dr Reddy’s, GRA and FUJIFILM for Avigan tablets
Signs agreement to coordinate and accelerate worldwide development, commercialisation, and distribution of Avigan tablets
COVID-19 drug research may drag on into July: Fujifilm
Researchers have only been able to get around 70 per cent of the patients needed for the trials
Fujifilm research into COVID-19 drug spills into June, dashing hope of May approval
“The company will continue research into next month or so, and if an application for approval is received from the company, it…
Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials
The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether…
Hikal announces development of Favipiravir APIs and its intermediates
The company is in discussion with potential partners to supply the API and its intermediates